Morris G, Vlachostergios PJ, Rai MP, Scherr D, Molina A, Elemento O, Mosquera JMiguel, Cheng L, Faltas BM.
2026.
19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.. Cancer Genet. 304-305:51-57.
Mak L, Tierney B, Wei W, Ronkowski C, Toscan RBrizola, Turhan B, Toomey M, Andrade-Martinez JSebastian, Fu C, Lucaci AG et al..
2026.
CAMP: a modular metagenomics analysis system for integrated multistep data exploration.. NAR Genom Bioinform. 8(1):lqaf172.
Agarwal PK, Sternberg CN.
2026.
Clinical trials corner issue 12(1).. Bladder Cancer. 12(1):23523735261424951.
Turco F, Gillessen S, Salfi G, Kloots ISH, Slootbeek PHJ, Mehra N, Labriola M, George DJ, Broderick A, Patrikidou A et al..
2026.
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.. Prostate Cancer Prostatic Dis.
Stenzl A, Rogers E, Ananiadou S, Wang Y, Armstrong AJ, Sboner A, Cacciamani G, Schijvenaars BJA, Ahmed KRiaz, Thomsen H et al..
2026.
Enhancing the quality and trustworthiness of large language model-generated summaries of clinical oncology literature.. JAMIA Open. 9(3):ooag078.
Kutler RB, Gantwerker E, Jotwani R, Sigaras A, Difede JA, Rameau A.
2026.
Extended Reality in Otolaryngology-Head & Neck Surgery: A State-of-the-Art Review.. Otolaryngol Head Neck Surg.
Okur V, Marcus A, Falcone JN, Hurd MA, Stewart SL, Claudio K, Manohar J, Dealla F, Kumar S, Yeung M et al..
2026.
Genome sequencing identifies monogenic causes in adults with metabolic diseases.. J Endocr Soc. 10(7):bvag091.
Uppal M, Bhinder B, Marderstein AR, Batlevi CLee, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD et al..
2026.
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.. J Clin Oncol. :JCO2501928.
Bleve S, Ravera F, Rodrigues S, Pederzoli F, Pakula H, Brighi N, Giunta EFrancesco, Schepisi G, Virga A, Gurioli G et al..
2026.
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.. Prostate Cancer Prostatic Dis.